Lumida
/XENE
⌘K
Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc

XENE
$68.26USD+1.91%+1.28 today

MARKET CAP

6.6B

P/E (TTM)

FWD P/E

DAY RANGE

$66 – $70

52W RANGE

$30
$73

AI Summary

Stalk
StalkMedium

XENE remains in a high-confidence Stage 2 uptrend with a clear sequence of higher highs and higher lows and sustained support from rising EMAs. However, price is extremely overbought and extended above its mid-cycle moving averages, creating limited near-term entry opportunities. We will stalk for a controlled pullback into the rising EMA ribbon or prior resistance-turned-support zones before committing to new long exposure.

  • 53.2% reduction in monthly seizures supports AZK’s efficacy and regulatory prospects
  • $691.1M cash on hand funds operations into 2027, highlighting strong liquidity
  • Negative earnings yield and unprofitable operations raise financial viability concerns
Full analysis →
Insider Trades13 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 13, 2026SellXENEAndrea DifabioChief Legal Officer1,342$55.22$6.6B-6.06%+127.53%$74.1K-6.75%10b5-1Stalk
Mar 13, 2026SellXENEChristopher John KenneyChief Medical Officer1,410$55.23$6.6B-6.06%+127.53%$77.9K-7.15%10b5-1Stalk
Mar 13, 2026SellXENEIan MortimerPRESIDENT & CEO7,308$55.23$6.6B-6.06%+127.53%$403.6K-11.29%10b5-1Stalk
Mar 10, 2026SellXENEAndrea DifabioChief Legal Officer2,607$60.11$6.6B-6.06%+127.53%$156.7K-17.38%10b5-1Stalk
Mar 10, 2026SellXENEChristopher John KenneyChief Medical Officer2,771$60.11$6.6B-6.06%+127.53%$166.6K-18.47%10b5-1Stalk
Mar 9, 2026SellXENEIan MortimerPRESIDENT & CEO551,269$34.08$6.6B-6.06%+127.53%$18.8M-2.05%10b5-1Stalk
Jan 2, 2026SellXENEIan MortimerPRESIDENT & CEO80,000$25.96$6.6B-6.06%+127.53%$2.1M+0.00%10b5-1Stalk
Dec 5, 2025SellXENEIan MortimerPRESIDENT & CEO25,205$45.33$6.6B-6.06%+127.53%$1.1M-44.97%10b5-1Stalk
Nov 28, 2025SellXENEIan MortimerPRESIDENT & CEO97$45.01$6.6B-6.06%+127.53%$4.4K-0.31%10b5-1Stalk
Oct 1, 2025SellXENEIan MortimerPRESIDENT, CEO & INTERIM CFO50,000$23.93$6.6B-6.06%+127.53%$1.2M+0.00%10b5-1Stalk
Jan 23, 2025SellXENEIan MortimerPRESIDENT & CEO110,000$29.01$6.6B-6.06%+127.53%$3.2M+0.00%10b5-1Stalk
Dec 18, 2024SellXENESherry AulinChief Financial Officer50,668$26.01$6.6B-6.06%+127.53%$1.3M+0.00%Stalk
Mar 7, 2024SellXENESherrington RobinEVP, Strategy & Innovation17,282$28.04$6.6B-6.06%+127.53%$484.5K+0.00%Stalk